NZ509505A - Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies - Google Patents
Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergiesInfo
- Publication number
- NZ509505A NZ509505A NZ509505A NZ50950599A NZ509505A NZ 509505 A NZ509505 A NZ 509505A NZ 509505 A NZ509505 A NZ 509505A NZ 50950599 A NZ50950599 A NZ 50950599A NZ 509505 A NZ509505 A NZ 509505A
- Authority
- NZ
- New Zealand
- Prior art keywords
- allergies
- derivatives
- preventing
- heterocyclyl
- aralkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Use of bisphosphonic acid compounds of formula (I) and their salts, esters or prodrugs for the treatment and prevention of autoimmune disorders, wherein; A1, A2, A3, A4 are hydrogen, optionally substituted alkyl, aryl, aralkyl, cycloalkyl or heterocyclyl, a metal from the first, second or third main group of the periodic table or an ammonium group or substituted ammonium moiety, which is derived from ethylenediamine or an amino acid; X is alkylene, alkenylene or hydroxyalkylene, or a bond; R1, R2 are H, OH, NH2, optionally substituted alkyl, acyl, aryl, aralkyl, cycloalkyl or heterocyclyl, SR3, Cl or NR3R4; and R3, R4 are H, OH, or optionally substituted alkyl, acyl, aryl, aralkyl, cycloalkyl or heterocyclyl. Bisphosphonic acid compounds of formula (I), when co-administered with autoantigens or allergens, act synergistically to treat a range of autoimmune disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19828450A DE19828450A1 (en) | 1998-06-26 | 1998-06-26 | Use of bisphosphonic acid compounds and autoantigens or allergens |
PCT/DE1999/001844 WO2000000182A2 (en) | 1998-06-26 | 1999-06-24 | Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ509505A true NZ509505A (en) | 2002-11-26 |
Family
ID=7872064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ509505A NZ509505A (en) | 1998-06-26 | 1999-06-24 | Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1089761B1 (en) |
JP (1) | JP2002519319A (en) |
KR (1) | KR20010053211A (en) |
AT (1) | ATE224734T1 (en) |
AU (1) | AU740605B2 (en) |
CA (1) | CA2334711C (en) |
DE (2) | DE19828450A1 (en) |
DK (1) | DK1089761T3 (en) |
EA (1) | EA200100080A1 (en) |
EE (1) | EE200000756A (en) |
ES (1) | ES2184496T3 (en) |
HR (1) | HRP20000820A2 (en) |
HU (1) | HUP0102873A3 (en) |
ID (1) | ID27515A (en) |
IL (1) | IL139966A0 (en) |
IS (1) | IS5748A (en) |
MX (1) | MXPA00012338A (en) |
NO (1) | NO20006572L (en) |
NZ (1) | NZ509505A (en) |
PL (1) | PL345287A1 (en) |
PT (1) | PT1089761E (en) |
SK (1) | SK19602000A3 (en) |
TR (1) | TR200003821T2 (en) |
WO (1) | WO2000000182A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL349438A1 (en) | 1998-12-23 | 2002-07-29 | Jomaa Pharmaka Gmbh | Use of bisphosphonates for the prevention and treatment of infectious processes |
CN1217666C (en) * | 1998-12-25 | 2005-09-07 | 东丽株式会社 | Interleukin-6 production inhibitors |
JP2004528365A (en) * | 2001-05-02 | 2004-09-16 | ノバルティス アクチエンゲゼルシャフト | Inhaled bisphosphonate administration method for treatment or prevention of bone resorption and osteoporosis |
ES2315411T3 (en) | 2001-07-20 | 2009-04-01 | Bioagency Ag | ORGANOFOSPHORATED COMPOUNDS FOR THE ACTIVATION OF T GAMMA / DELTA CELLS. |
GB0307989D0 (en) * | 2003-04-07 | 2003-05-14 | Mcewen Lab Ltd | Therapeutic composition |
EP1713489B1 (en) * | 2004-08-23 | 2011-01-19 | Teva Pharmaceutical Industries Ltd | Crystalline form of ibandronate sodium and processes for preparation thereof |
WO2007032808A1 (en) * | 2005-09-12 | 2007-03-22 | Dr. Reddy's Laboratories Ltd. | Crystalline trihydrate of zoledronic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993005052A1 (en) * | 1991-09-05 | 1993-03-18 | Toray Industries, Inc. | Methanediphosphonic acid derivative, production thereof and medicinal use thereof |
ATE219945T1 (en) * | 1995-01-23 | 2002-07-15 | Xenotech Inc | COMPOSITION FOR PREVENTING OSTEOLYSIS AND METASTASES |
-
1998
- 1998-06-26 DE DE19828450A patent/DE19828450A1/en not_active Withdrawn
-
1999
- 1999-06-24 EE EEP200000756A patent/EE200000756A/en unknown
- 1999-06-24 SK SK1960-2000A patent/SK19602000A3/en unknown
- 1999-06-24 KR KR1020007014813A patent/KR20010053211A/en not_active Application Discontinuation
- 1999-06-24 TR TR2000/03821T patent/TR200003821T2/en unknown
- 1999-06-24 NZ NZ509505A patent/NZ509505A/en not_active IP Right Cessation
- 1999-06-24 ES ES99941383T patent/ES2184496T3/en not_active Expired - Lifetime
- 1999-06-24 MX MXPA00012338A patent/MXPA00012338A/en unknown
- 1999-06-24 ID IDW20002676A patent/ID27515A/en unknown
- 1999-06-24 IL IL13996699A patent/IL139966A0/en unknown
- 1999-06-24 JP JP2000556767A patent/JP2002519319A/en active Pending
- 1999-06-24 DK DK99941383T patent/DK1089761T3/en active
- 1999-06-24 CA CA002334711A patent/CA2334711C/en not_active Expired - Fee Related
- 1999-06-24 PT PT99941383T patent/PT1089761E/en unknown
- 1999-06-24 DE DE59902856T patent/DE59902856D1/en not_active Expired - Lifetime
- 1999-06-24 PL PL99345287A patent/PL345287A1/en unknown
- 1999-06-24 HU HU0102873A patent/HUP0102873A3/en unknown
- 1999-06-24 AT AT99941383T patent/ATE224734T1/en active
- 1999-06-24 EA EA200100080A patent/EA200100080A1/en unknown
- 1999-06-24 AU AU55033/99A patent/AU740605B2/en not_active Ceased
- 1999-06-24 WO PCT/DE1999/001844 patent/WO2000000182A2/en not_active Application Discontinuation
- 1999-06-24 EP EP99941383A patent/EP1089761B1/en not_active Expired - Lifetime
-
2000
- 2000-11-29 HR HR20000820A patent/HRP20000820A2/en not_active Application Discontinuation
- 2000-12-01 IS IS5748A patent/IS5748A/en unknown
- 2000-12-21 NO NO20006572A patent/NO20006572L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20006572L (en) | 2001-02-21 |
IL139966A0 (en) | 2002-02-10 |
EA200100080A1 (en) | 2001-06-25 |
ATE224734T1 (en) | 2002-10-15 |
WO2000000182A2 (en) | 2000-01-06 |
ES2184496T3 (en) | 2003-04-01 |
DE19828450A1 (en) | 1999-12-30 |
CA2334711C (en) | 2006-12-05 |
SK19602000A3 (en) | 2001-07-10 |
JP2002519319A (en) | 2002-07-02 |
DK1089761T3 (en) | 2003-02-03 |
IS5748A (en) | 2000-12-01 |
KR20010053211A (en) | 2001-06-25 |
HUP0102873A3 (en) | 2002-04-29 |
EP1089761B1 (en) | 2002-09-25 |
AU5503399A (en) | 2000-01-17 |
AU740605B2 (en) | 2001-11-08 |
HRP20000820A2 (en) | 2001-12-31 |
TR200003821T2 (en) | 2001-06-21 |
PL345287A1 (en) | 2001-12-03 |
EE200000756A (en) | 2002-04-15 |
CA2334711A1 (en) | 2000-01-06 |
WO2000000182A3 (en) | 2000-03-30 |
ID27515A (en) | 2001-04-12 |
DE59902856D1 (en) | 2002-10-31 |
HUP0102873A2 (en) | 2001-12-28 |
EP1089761A2 (en) | 2001-04-11 |
MXPA00012338A (en) | 2003-04-25 |
NO20006572D0 (en) | 2000-12-21 |
PT1089761E (en) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL133891A (en) | Valproenoic acid amide derivatives and pharmaceutical compositions containing them | |
IL147595A0 (en) | Bicyclonucleoside analogues, oligonucleotide analogues and pharmaceutical compositions containing the same | |
CA2216129A1 (en) | Lactam-containing hydroxamic acids | |
MX9408969A (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles. | |
HUP0102471A2 (en) | 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists and pharmaceutical compositions containing them | |
MY100022A (en) | Medical composition for external application | |
IE811566L (en) | Steel articles protected against corrosion. | |
BG104998A (en) | Isothiazole derivatives useful as anticancer agents | |
MY109846A (en) | Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them | |
HK1065258A1 (en) | Benzothiazepine and benzothiadiazepine derivativeswith ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia | |
AP1541A (en) | New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors. | |
IL104090A (en) | Phosphonosuccinic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds | |
NZ336623A (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines for use in the treatment and prevention of disorders of the central nervous system | |
MX9505130A (en) | Aromatically substituted w-aminoalkanoic acid amides and alkanoic acid diamides. | |
BR9712424A (en) | Deneurotrophin antagonist pharmaceutical composition | |
HUP0003298A2 (en) | Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders | |
NZ509505A (en) | Medicaments containing bisphosphonic acids and derivatives thereof which are provided for preventing and treating autoimmune diseases and allergies | |
MX9800704A (en) | Esters and amides as pla2 inhibitors. | |
MXPA94001822A (en) | Acyloxyhexanoic acid derivative. | |
ZA929529B (en) | Pharmaceutical composition for the improvement of dysuria. | |
MD1431G2 (en) | Antihypotensive remedies | |
EP0473993A3 (en) | Novel peptide derivatives and their pharmaceutical use | |
ES2075798A1 (en) | Natural amino acid derivatives as inhibitors of metal proteinases, process for their preparation, pharmaceutical compositions containing them and use of the said compounds in medicine. | |
ES8702420A1 (en) | Aminoalkyl penem compounds. | |
GR3035010T3 (en) | New derivatives of glycylanilides, preparation and therapeutical application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: JOMAA PHARMAKA GMBH, DE Free format text: OLD OWNER(S): HASSAN JOMAA |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
S881 | Correction of error according section 88(1) (mistake in register by reason of an error or omission on the part of the patent office) |
Free format text: THE COMPLETE SPECIFICATION HAS BEEN CORRECTLY WITH THE INCLUSION OF PAGE 16 & 17 WHICH HAD BEEN OMITTED |
|
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
EXPY | Patent expired |